Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 36,659 | 31,602 | 28,844 | 19,786 | 17,277 |
| Cost of Goods | 13,588 | 14,962 | 11,572 | 7,576 | 5,231 |
| Gross Profit | 23,071 | 16,640 | 17,272 | 12,210 | 12,046 |
| Operating Expenses | 75,438 | 82,302 | 69,158 | 54,566 | 51,130 |
| Operating Income | -51,779 | -64,700 | -51,314 | -41,780 | -38,853 |
| Other Income | 1,557 | 1,688 | 1,755 | 3,434 | 183 |
| Pre-tax Income | -50,222 | -63,012 | -49,559 | -38,346 | -38,670 |
| Net Income Continuous | -50,222 | -63,012 | -49,559 | -38,346 | -38,670 |
| Net Income | $-50,222 | $-63,012 | $-49,559 | $-38,346 | $-38,670 |
| EPS Basic Total Ops | -0.63 | -0.80 | -0.60 | -0.49 | -0.54 |
| EPS Basic Continuous Ops | -0.63 | -0.80 | -0.61 | -0.49 | -0.54 |
| EPS Diluted Total Ops | -0.63 | -0.80 | -0.60 | -0.49 | -0.54 |
| EPS Diluted Continuous Ops | -0.63 | -0.80 | -0.61 | -0.49 | -0.54 |
| EBITDA(a) | $-52,107 | $-65,343 | $-52,150 | $-42,228 | $-38,958 |